Clinical Trial Update: PREvent First Episode Relapse (PREFER) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for PREvent First Episode Relapse (PREFER) in schizophrenia, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: State University of New York - Downstate Medical Center | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN